Pradžia › Kraujos vėžys
Kraujos vėžys klinikiniai tyrimai JAV ieško dalyvių
153 tyrimai dėl Kraujos vėžys ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Houston, TX46 tyrimai
- New York City, NY26 tyrimai
- Boston, MA25 tyrimai
- Washington, DC19 tyrimai
- Baltimore, MD18 tyrimai
- Seattle, WA18 tyrimai
- Los Angeles, CA17 tyrimai
- Durham, NC16 tyrimai
- Chicago, IL15 tyrimai
- Philadelphia, PA14 tyrimai
- Nashville, TN13 tyrimai
- Atlanta, GA13 tyrimai
- Edison, NJ13 tyrimai
- Baldwin Park, CA13 tyrimai
- Columbus, OH13 tyrimai
- Milwaukee, WI12 tyrimai
- Dallas, TX12 tyrimai
- Detroit, MI12 tyrimai
- Minneapolis, MN11 tyrimai
- Ann Arbor, MI11 tyrimai
- Birmingham, AL11 tyrimai
- Omaha, NE10 tyrimai
- Cincinnati, OH10 tyrimai
- St. Louis, MO10 tyrimai
- Jacksonville, FL10 tyrimai
- Miami, FL9 tyrimai
- Cedar Rapids, IA9 tyrimai
- Memphis, TN9 tyrimai
- Denver, CO9 tyrimai
- San Antonio, TX8 tyrimai
- Aurora, CO8 tyrimai
- San Francisco, CA8 tyrimai
- Salt Lake City, UT8 tyrimai
- Clifton, NJ8 tyrimai
- Tampa, FL8 tyrimai
- Buffalo, NY7 tyrimai
- Madison, WI7 tyrimai
- Charlotte, NC7 tyrimai
- Grand Rapids, MI7 tyrimai
- Orange, CA7 tyrimai
Pagal valstiją
- Ajova9 tyrimai
- Alabama11 tyrimai
- Arizona12 tyrimai
- Arkansas5 tyrimai
- Delaveras3 tyrimai
- Džordžija16 tyrimai
- Florida28 tyrimai
- Ilinoisas16 tyrimai
- Indianas9 tyrimai
- Kalifornija35 tyrimai
- Kanzasas7 tyrimai
- Kentukis10 tyrimai
- Koloradas14 tyrimai
- Kolumbijos apskritis7 tyrimai
- Konektikutas8 tyrimai
- Luiziana6 tyrimai
- Masčusetsas26 tyrimai
- Merilendas29 tyrimai
- Minesota17 tyrimai
- Misūris11 tyrimai
- Mičiganas22 tyrimai
- Naujoji Hampšyras3 tyrimai
- Nebraska10 tyrimai
- Nevada4 tyrimai
- New Jersey21 tyrimas
- New York29 tyrimai
- North Carolina24 tyrimai
- Ohio22 tyrimai
- Oklahoma8 tyrimai
- Oregon8 tyrimai
- Pennsylvania21 tyrimas
- Rhode Island4 tyrimai
- South Carolina8 tyrimai
- South Dakota5 tyrimai
- Tennessee20 tyrimai
- Texas49 tyrimai
- Utah8 tyrimai
- Virginia11 tyrimai
- Washington20 tyrimai
- West Virginia5 tyrimai
- Wisconsin15 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 110 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05724121Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Renkami dalyviai1 fazė
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06904066Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT03486873Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069Rutgers University Study of the Genetics of Blood Cancers
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 110 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07714044Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 0 iki 38 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06131801A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06697184A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07572006A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT04634552Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06910969Genomic Profiling in Cancer Patients
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-24 · NCT01775072Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT06398457Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT04728893Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Renkami dalyviai3 fazė
Amžius nuo 18 iki 71 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07504458Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345Wearable Activity Tracking to Curb Hospitalizations
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT06587100Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius nuo 12 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT04744116Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 12 iki 120 · Visoms lytims · Atnaujinta 2026-09-22 · NCT05470491Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
Renkami dalyviai1 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07162038Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT07648264Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-18 · NCT07743476Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 12 iki 120 · Visoms lytims · Atnaujinta 2026-09-18 · NCT05327023Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-17 · NCT04242095SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT05375643Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
Renkami dalyviai1 fazė
Iki 75 metų · Visoms lytims · Atnaujinta 2026-09-16 · NCT06345027Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.